Anaptysbio ANAB
NASDAQ ANAB
$56.80 -0.66 (-1.15%)
As of: Sep 4, 2026 · 3:59 PM EDT

Anaptysbio (ANAB) Prepaid Assets (2016 - 2026)

Anaptysbio's (ANAB) quarterly Prepaid Assets came in at $3.9 million in Q1 2026, down 26.17% YoY from $5.3 million in Q1 2025, and down 17.95% on a QoQ basis from $4.8 million in Q4 2025.

Analysis

Anaptysbio (ANAB) Prepaid Assets (2016 - 2026) Analysis & Trends

Anaptysbio (ANAB) has 11 years of Prepaid Assets data on file, last reported at $3.9 million in Q1 2026.

  • Quarterly Prepaid Assets fell 26.17% year-over-year to $3.9 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.9 million (down 26.17% YoY) and the FY2025 annual result came in at $4.8 million, down 17.01% from the prior year.
  • Prepaid Assets fell to $3.9 million in Q1 2026, from $4.8 million in the prior quarter.
  • In the past five years, Prepaid Assets ranged from a high of $11.7 million in Q3 2023 to a low of $3.9 million in Q1 2026.
  • A 5-year average of $6.6 million and a median of $5.9 million in 2022 frame the typical range for Prepaid Assets.
  • Annual changes were most pronounced in 2024 — Prepaid Assets surged 138.08% — and 2025, when it plunged 50.38%.
  • Tracing ANAB's Prepaid Assets over 5 years: stood at $4.5 million in 2022, then soared by 99.78% to $9.1 million in 2023, then slumped by 36.81% to $5.7 million in 2024, then slipped by 17.01% to $4.8 million in 2025, then fell by 17.95% to $3.9 million in 2026.
  • The last three Prepaid Assets figures came in at $3.9 million (Q1 2026), $4.8 million (Q4 2025), and $6.0 million (Q3 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Anaptysbio 1.62 Bn 1.34 Bn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 3.91 Mn
Dec 31, 2025 4.76 Mn
Sep 30, 2025 6.01 Mn
Jun 30, 2025 4.78 Mn
Mar 31, 2025 5.29 Mn
Dec 31, 2024 5.74 Mn
Sep 30, 2024 6.37 Mn
Jun 30, 2024 7.54 Mn
Mar 31, 2024 10.67 Mn
Dec 31, 2023 9.08 Mn
Sep 30, 2023 11.68 Mn
Jun 30, 2023 5.87 Mn
Mar 31, 2023 4.48 Mn
Dec 31, 2022 4.55 Mn
Sep 30, 2022 6.30 Mn
Jun 30, 2022 9.63 Mn
Mar 31, 2022 5.87 Mn
Dec 31, 2021 4.90 Mn
Sep 30, 2021 11.76 Mn
Jun 30, 2021 6.51 Mn